MoneyWorks4Me

Sudeep Pharma - Quaterly Results

22 May 2026 Evaluate
Net sales declined -23.54%  to  Rs. 801.67 million from Rs. 1048.52 millions.Net profit declined -22.25% to Rs. 257.64 millions from Rs. 331.36 millions.The Operating Profit of the company witnessed a decrease to 385.04 millions from 485.63 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 801.67 1048.52 -23.54 3385.05 3567.32 -5.11 3385.05 3567.32 -5.11
Other Income 96.19 30.98 210.49 385.04 83.76 359.69 385.04 83.76 359.69
PBIDT 385.04 485.63 -20.71 1582.72 1403.33 12.78 1582.72 1403.33 12.78
Interest 19.69 15.76 24.94 60.66 48.10 26.11 60.66 48.10 26.11
PBDT 365.35 469.87 -22.24 1522.06 1355.23 12.31 1522.06 1355.23 12.31
Depreciation 17.93 17.06 5.10 71.10 61.17 16.23 71.10 61.17 16.23
PBT 347.42 452.81 -23.27 1450.96 1294.06 12.12 1450.96 1294.06 12.12
TAX 89.78 121.45 -26.08 375.16 336.59 11.46 375.16 336.59 11.46
Deferred Tax 17.92 1.67 973.05 31.93 5.26 507.03 31.93 5.26 507.03
PAT 257.64 331.36 -22.25 1075.80 957.47 12.36 1075.80 957.47 12.36
Equity 112.95 97.23 16.17 112.95 97.23 16.17 112.95 97.23 16.17
PBIDTM(%) 48.03 46.32 3.70 46.76 39.34 18.86 46.76 39.34 18.86
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..